Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART
Clinical trial NCT06908083 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06908083
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2028-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.